MedPath

MEDICEM Technology s.r.o.

🇨🇿Czech Republic
Ownership
-
Employees
-
Market Cap
-
Website

Dilapan-S®: A Multicenter US E-registry

Active, not recruiting
Conditions
Gestational Diabetes
Fetal Growth Retardation
High Blood Pressure in Pregnancy
Post Term Pregnancy
Premature Rupture of Membrane
Oligohydramnios
Interventions
Device: Dilapan-S
First Posted Date
2020-06-30
Last Posted Date
2024-11-22
Lead Sponsor
Medicem Technology s.r.o.
Target Recruit Count
1200
Registration Number
NCT04451109
Locations
🇺🇸

The University of Texas Medical Branch, Galveston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath